These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 13386976

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Central Nervous System Brucellosis Granuloma and White Matter Disease in Immunocompromised Patient.
    Alqwaifly M, Al-Ajlan FS, Al-Hindi H, Al Semari A.
    Emerg Infect Dis; 2017 Jun; 23(6):978-981. PubMed ID: 28518039
    [Abstract] [Full Text] [Related]

  • 23. Host response to Brucella infection: review and future perspective.
    Elfaki MG, Alaidan AA, Al-Hokail AA.
    J Infect Dev Ctries; 2015 Jul 30; 9(7):697-701. PubMed ID: 26230118
    [Abstract] [Full Text] [Related]

  • 24. [Relationship between the duration of the clinical course of human brucellosis and the avidity of specific IgG antibodies].
    Gutiérrez J, Rodríguez M, Maroto MC.
    Rev Med Chil; 1995 Jul 30; 123(7):819-22. PubMed ID: 8560111
    [Abstract] [Full Text] [Related]

  • 25. Pathogenesis and immunobiology of brucellosis: review of Brucella-host interactions.
    de Figueiredo P, Ficht TA, Rice-Ficht A, Rossetti CA, Adams LG.
    Am J Pathol; 2015 Jun 30; 185(6):1505-17. PubMed ID: 25892682
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Research on the transmission of brucellar and typhic agglutinins by electrophoretic protein fractions; first study with a new method].
    BOTTONE E, TOSI E.
    Minerva Med; 1956 Nov 24; 47(94):1725-7. PubMed ID: 13387327
    [No Abstract] [Full Text] [Related]

  • 28. Prevalence of Brucella antibodies after acute brucellosis.
    Almuneef M, Memish ZA.
    J Chemother; 2003 Apr 24; 15(2):148-51. PubMed ID: 12797392
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Evaluation of plasma sphingosine 1-phosphate, hepcidin and cardiovascular damage biomarkers (cardiac troponin I and homocysteine) in rats infected with brucellosis and vaccinated (Rev-1, RB-51).
    Azimzadeh K, Nasrollahi Nargesabad R, Vousooghi N.
    Microb Pathog; 2017 Aug 24; 109():67-70. PubMed ID: 28533142
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Lymphoblastic transformation by fractions of Brucella in patients having had brucellosis and subjects vaccinated by the vaccine PI].
    Peraldi M, Lopez A, Lacave C, Bascoul S, Serre A.
    Dev Biol Stand; 1976 Aug 24; 31():157-64. PubMed ID: 1261734
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The use of gel diffusion precipitin plates in the study of Brucella.
    BRUCE W, JONES LM.
    Bull World Health Organ; 1958 Aug 24; 19(1):187-96. PubMed ID: 13585068
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Comparison of Brucella immunoglobulin M and G flow assays with serum agglutination and 2-mercaptoethanol tests in the diagnosis of brucellosis.
    Zeytinoğlu A, Turhan A, Altuğlu I, Bilgiç A, Abdoel TH, Smits HL.
    Clin Chem Lab Med; 2006 Aug 24; 44(2):180-4. PubMed ID: 16475904
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.